Press Releases

Date Title and Summary
Toggle Summary Accuray to Set ASTRO 2019 in Motion with Patient-first Cancer Treatment Innovations
SUNNYVALE, Calif. , Sept. 5, 2019 /PRNewswire/ -- Accuray Incorporated  (NASDAQ: ARAY) announced today that it will showcase its industry-leading motion-synchronization cancer treatment technologies at the upcoming American Society for Radiation Oncology (ASTRO) Annual Meeting taking place
Toggle Summary Accuray to Host ASTRO Investor Meeting on September 16, 2019
Presentations will be Live Webcast and Commence at 3:00pm CT SUNNYVALE, Calif. , Sept. 4, 2019 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) announced today that the Company will host an Investor Meeting during the American Society of Radiation Oncology (ASTRO) Annual Meeting, being held
Toggle Summary Froedtert & the Medical College of Wisconsin Cancer Network is First in the World to Treat Cancer Patient Using the Accuray Radixact® System with Synchrony® Motion Tracking and Correction Technology
Advanced Radiation Therapy Delivery System and Intrafraction Motion Synchronization Functionality Enable Precise, Efficient Treatment of a 45-Year-Old Man with Lung Cancer SUNNYVALE, Calif. , Aug. 21, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that physicians at the
Toggle Summary Accuray Reports Fourth Quarter and Fiscal 2019 Financial Results
SUNNYVALE, Calif. , Aug. 15, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2019 . Q4 Fiscal 2019 and Recent Operating Highlights Revenue increased 3 percent to $117.4 million , the highest ever
Toggle Summary New Data Demonstrating Benefits of Accuray Software Solutions Presented at the Annual Meeting of the American Association of Physicists in Medicine
SUNNYVALE, Calif. , July 24, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that studies validating the benefits of CyberKnife ®  and Radixact ®  System software innovations were shared by prominent physicists at the recent 61 st annual meeting of the American Association
Toggle Summary Accuray Provides Update on China Joint Venture Operational Progress
SUNNYVALE, Calif. , July 23, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today provided an update on the operational progress of its China joint venture, CNNC Accuray (Tianjin) Medical Technology Co., Ltd (CNNC Accuray). CNNC Accuray has received the Radiation Safety License from the
Toggle Summary Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019
SUNNYVALE, Calif. , July 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m.
Toggle Summary Swiss Medical Network Advances Cancer Care in Switzerland with Multi-System Agreement for Accuray Radiation Therapy Systems and RaySearch Oncology Software Systems
First Multi-System Agreement by a Hospital for Both Accuray and RaySearch Products The Swiss Medical Network, Accuray and RaySearch Have Also Partnered to Expand Opportunities for Training Healthcare Professionals on the Latest Technologies SUNNYVALE, Calif.
Toggle Summary Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System
Hospital is the First in Asia to Procure Synchrony for Radixact, Furthering Its Goal to Use Advanced Medical Technology to Improve Cancer Treatments SUNNYVALE, Calif. , May 1, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with Hong
Toggle Summary Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System
Only Radiotherapy System with Helical Delivery Capability and Intrafraction Motion Synchronization Functionality, Offering Expanded Versatility and Increased Precision in the Treatment of Simple to Complex Tumors SUNNYVALE, Calif. , April 24, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY)